Alpha 2.0
Login Register
» Articles » PMID: 4119363

The Enhanced Therapeutic Effect of Cis-platinum (II) Diamminodichloride Against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or Several Other Antitumor Agents

Overview
Journal Chemotherapy
Specialty Pharmacology
Date 1973 Jan 1
PMID 4119363
Citations 9
Authors
R J Woodman
A E Sirica
M Gang
I Kline
J M Venditti
Affiliations
Soon will be listed here.
Citing Articles

Combination chemotherapy.

Connors T Proc R Soc Med. 2010; 67(6 Pt 1):434-6.

PMID: 20919187 PMC: 1645715.

Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin.

Hofs H, Wagener D, van Rennes H, De Vos D, Doesburg W, Ottenheijm H Invest New Drugs. 1995; 13(1):23-32.

PMID: 7499104 DOI: 10.1007/BF02614216.

Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.

Becher R, Seeber S, SCHMIDT C J Cancer Res Clin Oncol. 1980; 97(3):301-6.

PMID: 7192287 DOI: 10.1007/BF00405782.

Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.

Sessa C, Bolis G, Colombo N, DIncalci M, Mermillod B, Valente I Cancer Chemother Pharmacol. 1985; 14(3):222-8.

PMID: 3922639 DOI: 10.1007/BF00258120.

Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.

Schafer E J Cancer Res Clin Oncol. 1987; 113(3):216-22.

PMID: 3584212 DOI: 10.1007/BF00396376.